Ambu (AMBU B) Stock Overview
Researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
AMBU B Community Fair Values
Create NarrativeSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 66.30 |
| 52 Week High | DKK 111.80 |
| 52 Week Low | DKK 56.25 |
| Beta | 1.39 |
| 1 Month Change | -13.39% |
| 3 Month Change | 7.02% |
| 1 Year Change | -32.76% |
| 3 Year Change | -12.49% |
| 5 Year Change | -69.06% |
| Change since IPO | 3,771.54% |
Recent News & Updates
Narrative Update • Sep 03
AMBU B: Maintained Margin Guidance May Support Repricing Despite Recent Downgrades
Analysts have trimmed their fair value estimate for Ambu stock from DKK 88.80 to DKK 85.20, reflecting updated assumptions around revenue growth, profit margins and rising competition cited in recent research downgrades. Analyst Commentary Recent analyst moves on Ambu underline a more cautious stance, with two downgrades since early 2025 and a lower fair value estimate now embedded in expectations.Analysis Article • Aug 28
Ambu A/S Just Missed Earnings - But Analysts Have Updated Their Models
Last week, you might have seen that Ambu A/S ( CPH:AMBU B ) released its quarterly result to the market. The early...
Narrative Update • Aug 15
AMBU B: Rising Competitive Pressure Will Drive More Cautious Share Performance
Analysts have raised their fair value estimate for Ambu to DKK 61 from DKK 58, while also reflecting slightly different assumptions for growth, margins and future P/E following recent research that highlights rising competitive pressure and a more cautious near term outlook. What’s in the News for Ambu Analysts revised their fair value estimate for Ambu to DKK 61 from DKK 58, reflecting updated assumptions on growth, margins and future P/E.
Narrative Update • Jul 15
AMBU B: Margin Resilience And Competitive Response Are Expected To Drive Future Upside
The analyst price target for Ambu has been cut from DKK 138.0 to DKK 116.4, as analysts adopt more cautious assumptions around competition, growth, margins, discount rate and future P/E following recent bearish research updates. Analyst Commentary Recent research on Ambu has leaned more cautious, with some price targets and ratings adjusted to reflect concerns about competition and the near term outlook.Recent updates
Narrative Update • Sep 03
AMBU B: Maintained Margin Guidance May Support Repricing Despite Recent Downgrades
Analysts have trimmed their fair value estimate for Ambu stock from DKK 88.80 to DKK 85.20, reflecting updated assumptions around revenue growth, profit margins and rising competition cited in recent research downgrades. Analyst Commentary Recent analyst moves on Ambu underline a more cautious stance, with two downgrades since early 2025 and a lower fair value estimate now embedded in expectations.Analysis Article • Aug 28
Ambu A/S Just Missed Earnings - But Analysts Have Updated Their Models
Last week, you might have seen that Ambu A/S ( CPH:AMBU B ) released its quarterly result to the market. The early...Narrative Update • Aug 15
AMBU B: Rising Competitive Pressure Will Drive More Cautious Share Performance
Analysts have raised their fair value estimate for Ambu to DKK 61 from DKK 58, while also reflecting slightly different assumptions for growth, margins and future P/E following recent research that highlights rising competitive pressure and a more cautious near term outlook. What’s in the News for Ambu Analysts revised their fair value estimate for Ambu to DKK 61 from DKK 58, reflecting updated assumptions on growth, margins and future P/E.Narrative Update • Jul 15
AMBU B: Margin Resilience And Competitive Response Are Expected To Drive Future Upside
The analyst price target for Ambu has been cut from DKK 138.0 to DKK 116.4, as analysts adopt more cautious assumptions around competition, growth, margins, discount rate and future P/E following recent bearish research updates. Analyst Commentary Recent research on Ambu has leaned more cautious, with some price targets and ratings adjusted to reflect concerns about competition and the near term outlook.Narrative Update • Jul 01
AMBU B: Rising Competition Will Weigh On Future Share Performance
The analyst price target for Ambu has been reduced from DKK 78 to DKK 58, with analysts citing a more cautious near term outlook and rising competition as key reasons for the change. Analyst Commentary Recent commentary on Ambu reflects a more cautious tone, with bearish analysts flagging concerns around the company’s ability to deliver against expectations as competition increases.Narrative Update • Jun 17
AMBU B: Bearish Downgrade And Stable Assumptions May Support Future Repricing
Analysts have reduced their price target on Ambu shares to DKK 88.8, citing a more cautious stance reflected in recent research, including a downgrade from Danske Bank. This comes even as underlying model inputs such as the discount rate, growth and future P/E assumptions remain broadly unchanged.Narrative Update • Jun 03
AMBU B: Bearish Street Sentiment Will Support Future Upside Repricing
Analysts have reduced their price target on Ambu to DKK 88.8, citing a more cautious stance reflected in recent bearish Street research and downgrades. What's in the News Analysts have adopted a more cautious stance on Ambu, reflected in recent bearish research and rating downgrades from the Street.Narrative Update • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.Analysis Article • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...Narrative Update • May 04
AMBU B: Higher Growth And Margins Are Expected To Support Future Upside
Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.Narrative Update • Apr 20
AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing
Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.Narrative Update • Apr 06
AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside
Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.Narrative Update • Mar 22
AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves
Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.Narrative Update • Mar 08
AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside
Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.Narrative Update • Feb 22
AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside
The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.Narrative Update • Feb 08
AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook
The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.Analysis Article • Feb 08
Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...Narrative Update • Jan 25
AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside
Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.Narrative Update • Jan 11
AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside
Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).Analysis Article • Jan 03
Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...Narrative Update • Dec 19
AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential
Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.Analysis Article • Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...Narrative Update • Dec 05
AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside
Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).Analysis Article • Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now
Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...Narrative Update • Nov 21
AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum
Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.Narrative Update • Nov 06
AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements
Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.Analysis Article • Oct 07
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Analysis Article • Aug 27
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...Analysis Article • Aug 11
Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?
CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...Analysis Article • Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...Analysis Article • May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye
The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...Analysis Article • Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analysis Article • Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...Analysis Article • Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Analysis Article • Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...Analysis Article • Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
New Narrative • Dec 16
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.Analysis Article • Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...Analysis Article • Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...Analysis Article • Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...Analysis Article • Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...Analysis Article • Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...Analysis Article • Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...Analysis Article • Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...Analysis Article • Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...Shareholder Returns
| AMBU B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -0.7% | -3.3% | -3.1% |
| 1Y | -32.8% | -18.0% | -1.9% |
Return vs Industry: AMBU B underperformed the Danish Medical Equipment industry which returned -18% over the past year.
Return vs Market: AMBU B underperformed the Danish Market which returned -1.9% over the past year.
Price Volatility
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in DK Market | 7.3% |
| 10% least volatile stocks in DK Market | 2.2% |
Stable Share Price: AMBU B's share price has been volatile over the past 3 months compared to the Danish market.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,200 | Britt Jensen | www.ambu.com |
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators.
Ambu A/S Fundamentals Summary
| AMBU B fundamental statistics | |
|---|---|
| Market cap | DKK 17.31b |
| Earnings (TTM) | DKK 510.00m |
| Revenue (TTM) | DKK 6.24b |
33.9x
P/E Ratio2.8x
P/S RatioIs AMBU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU B income statement (TTM) | |
|---|---|
| Revenue | DKK 6.24b |
| Cost of Revenue | DKK 2.49b |
| Gross Profit | DKK 3.75b |
| Other Expenses | DKK 3.24b |
| Earnings | DKK 510.00m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Nov 05, 2026
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 60.11% |
| Net Profit Margin | 8.18% |
| Debt/Equity Ratio | 0.3% |
How did AMBU B perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield21%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/15 23:13 |
| End of Day Share Price | 2026/09/15 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ambu A/S is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Susannah Ludwig | Bernstein |